navigation Menu
flower bullet

Transvaginal Mesh


To Mesh or Not to Mesh Part 2: Mesh and Stress Incontinence

November 14, 2016 | Dr. Janelle Morgan Evans, MS, MD, FACOG

Understanding Mesh
There is a common misperception since the fallout from the 2011 FDA warnings regarding polypropylene mesh products – that all mesh is very risky and can cause serious harm to a large percentage of patients. This change in public thinking and rampant reminder of mesh issues via legal advertisements and mailings has certainly changed the way that we, as Urogynecologists, counsel and treat patients. Read more


To Mesh or Not To Mesh Part 1: Mesh and Prolapse

November 7, 2016 | Dr. Janelle Morgan Evans, MS, MD, FACOG

Understanding Mesh
There is a common misperception since the fallout from the 2011 FDA warnings regarding polypropylene mesh products – that all mesh is very risky and can cause serious harm to a large percentage of patients. This change in public thinking and rampant reminder of mesh issues via legal advertisements and mailings has certainly changed the way that we, as Urogynecologists, counsel and treat patients. Read more


Transvaginal Mesh: An Overview

September 19, 2016 | Dr. Mary South, MD

The use of transvaginal mesh for the treatment of pelvic floor disorders has received a great deal of attention in the media over the past several years.  In 2008 (followed by an update in 2011), the FDA issued a public health notification to alert health care practitioners to the “complications associated with transvaginal placement of surgical mesh to treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). Read more